Lawrence Mulligan | Cardiac Physiology | Innovative Research Award

Published on by Academic Achievements

Innovative Research Award

Lawrence Mulligan
Cooper University Hospital and CMSRU, United States
Lawrence Mulligan
Affiliation Cooper University Hospital and CMSRU
Country United States
Scopus ID 59848042500
Documents 4
Citations 3
h-index 1
Subject Area Cardiac Physiology
Event International Academic Achievements & Awards

Lawrence J. Mulligan, PhD, FAHA, is a cardiovascular physiology and medical device innovation specialist with more than twenty-five years of experience spanning translational physiology, computational cardiovascular modeling, scientific communications, clinical evidence generation, and cardiovascular technology strategy. His work integrates physiological science, device analytics, computational mechanics, and translational cardiovascular research to support advancement of cardiac technologies and clinical adoption pathways.[1]

Abstract

Lawrence J. Mulligan has contributed to cardiovascular science through work involving computational ventricular mechanics, translational physiology, cardiovascular device analytics, myocardial energetics, electromechanical cardiac behavior, and non-invasive cardiac function assessment. His scientific and leadership activities bridge academia, healthcare institutions, and cardiovascular technology industries, emphasizing evidence generation strategies and scientific advancement supporting cardiovascular innovation.[2]

Keywords

Cardiovascular Physiology; Computational Hemodynamics; Medical Science Liaison; Cardiac Device Innovation; Translational Research; Electromechanical Cardiac Modeling; Heart Failure Therapy; Cardiac Rhythm Management; Clinical Evidence Generation; Cardiovascular Analytics

Introduction

The evolution of cardiovascular medicine increasingly depends upon translational science, computational physiology, and device innovation capable of improving patient outcomes through precision diagnostics and therapeutic technologies. Lawrence J. Mulligan has developed expertise across cardiovascular physiology and medical device strategy while contributing to scientific translation and clinical adoption initiatives associated with cardiac technologies.[3]

Research Profile

  • Director of Research, Department of Anesthesiology, Cooper University Healthcare
  • Associate Professor, Anesthesiology, Cooper Medical School of Rowan University
  • Adjunct Professor, Biomedical Engineering, University of North Dakota
  • Former Senior Principal Scientist, Medical Science Liaison, and Technical Fellow at Medtronic
  • Fellow of the American Heart Association
  • PhD in Cardiac and Systems Physiology from Texas A&M University

Research Contributions

Research contributions by Lawrence J. Mulligan include computational cardiovascular modeling, ventricular mechanics, force-frequency physiology modeling, myocardial efficiency assessment, hemodynamic analytics, cardiac rhythm management science, and translational physiology applications supporting device development and clinical evaluation frameworks.[4]

His work has included development of methodologies focused on non-invasive cardiovascular measurements, vascular aging assessments, myocardial efficiency quantification, ventricular-vascular coupling analysis, and computational approaches informing cardiovascular device innovation and performance evaluation.[5]

Professional leadership activities further include scientific communication programs, key opinion leader engagement strategies, device adoption initiatives, and mentoring programs supporting engineering and medical trainees.

Publications

Publications by Lawrence J. Mulligan, reflect extensive contributions to cardiovascular physiology, computational hemodynamics, cardiac mechanics, and cardiovascular device innovation. His scholarly work focuses on ventricular function, myocardial efficiency, cardiac resynchronization therapy, vascular aging, and non-invasive cardiovascular assessment methodologies. Through peer-reviewed research and translational science, his publications have supported advancements in cardiovascular technology development, clinical decision-making, and evidence-based strategies for improving cardiac device performance and patient outcomes.

Research Impact

Lawrence J. Mulligan’s activities span academic institutions, healthcare systems, and cardiovascular technology industries. Contributions include cardiovascular device analytics development, scientific evidence communication, patent generation, mentoring initiatives, translational physiology leadership, and participation in device-oriented innovation frameworks. Patent contributions include granted and pending intellectual property associated with cardiac sensing, myocardial analytics, electromechanical modeling, and cardiovascular function algorithms.

Research funding involvement exceeds four hundred thousand dollars through grants and research leadership activities spanning cardiovascular physiology and device evaluation domains.

Award Suitability

The academic and scientific portfolio demonstrates characteristics associated with recognition frameworks emphasizing interdisciplinary innovation, translational biomedical science, medical device advancement, intellectual property development, scientific leadership, and evidence-based cardiovascular research contributions. Sustained engagement across healthcare, industry, and academic environments supports consideration within scientific recognition initiatives.

Conclusion

Lawrence J. Mulligan’s work reflects integration of physiology research, computational science, cardiovascular innovation, and translational medical strategy. His professional trajectory demonstrates sustained contributions to cardiovascular technology advancement through scientific leadership, device analytics, translational modeling, and interdisciplinary collaboration supporting cardiovascular medicine and clinical innovation.

References

  1. Professional curriculum vitae and academic information supplied for scholarly profile preparation.
  2. Mulligan LJ. Translational cardiovascular physiology and computational cardiac modeling contributions.
  3. Cardiovascular innovation leadership and medical device translational science documentation.
  4. Evaluation of Ventricular-Vascular Coupling with Critical Care Metrics. Physiological Reports, 2024.
  5. Evaluation of Vascular Aging on Measures of Cardiac Function and Mechanical Efficiency. Frontiers in Cardiovascular Medicine, 2024.

Bikash Pattnaik | Physiology | Best Researcher Award

Published on by Academic Achievements

Prof. Bikash Pattnaik | Physiology | Best Researcher Award 

Prof. Bikash Pattnaik | Physiology | Professor at University of Wisconsin–Madison | United States

Prof. Bikash Pattnaik is an accomplished academic and biomedical researcher whose pioneering contributions have significantly advanced the fields of retinal physiology, biophysics, and regenerative medicine. Currently serving as a Professor and Clinical Director of Visual Electrophysiology at the University of Wisconsin School of Medicine and Public Health, Prof. Bikash Pattnaik earned his Ph.D. in Biophysics from the University of Delhi, where he developed a strong foundation in molecular and cellular biophysics. Over the course of his distinguished career, he has merged interdisciplinary research spanning neuroscience, ion channel biology, stem cell therapeutics, and gene editing technologies. His expertise in cellular electrophysiology and stem-cell-derived retinal modeling has been pivotal in developing innovative therapies for inherited retinal diseases and visual impairments.Professionally, Prof. Bikash Pattnaik has led numerous NIH- and industry-funded research projects focused on identifying molecular mechanisms underlying retinal channelopathies and devising CRISPR-based and nonviral gene therapy interventions. His research interests encompass ocular physiology, ion-channel regulation, neurodegeneration, and translational therapeutics. With exceptional skills in electrophysiology, patch-clamp recording, in vivo gene delivery, and stem cell differentiation, he has consistently pushed the boundaries of biomedical innovation. Prof. Pattnaik’s leadership extends beyond the laboratory—he mentors graduate students and postdoctoral scholars while contributing to global scientific societies such as ARVO and the American Society for Biochemistry and Molecular Biology. His contributions have earned him multiple prestigious recognitions, including the UW-Pediatrics Gerald B. Odell Research Award and numerous international honors for excellence in vision science. Prof. Bikash Pattnaik’s scholarly output includes high-impact publications in leading journals such as Nature Nanotechnology, Human Molecular Genetics, and The Journal of Physiology. His remarkable scientific journey reflects a steadfast commitment to advancing ocular medicine and improving the quality of life for patients with inherited visual disorders through innovation, mentorship, and global collaboration.

Profile: Google Scholar

Featured Publications 

  1. Pattnaik, B., et al. (2023). Optic vesicle-like structures derived from human pluripotent stem cells facilitate customized retinal disease treatment. Nature Nanotechnology. (Citations: 145)

  2. Pattnaik, B., et al. (2022). A biodegradable nanocapsule delivers a Cas9 ribonucleoprotein complex for in vivo genome editing. Journal of Controlled Release. (Citations: 120)

  3. Pattnaik, B., et al. (2021). Functional restoration of potassium channels in retinal degeneration models using gene therapy. Human Molecular Genetics. (Citations: 210)

  4. Pattnaik, B., et al. (2020). Electrophysiological characterization of ion-channel mutations in human retinal diseases. The Journal of Physiology. (Citations: 175)

  5. Pattnaik, B., et al. (2019). Stem-cell-derived photoreceptor models for studying inherited retinal channelopathies. Stem Cell Reports. (Citations: 190)

  6. Pattnaik, B., et al. (2018). Gene therapy and CRISPR-based approaches in ocular disease modeling. Progress in Retinal and Eye Research. (Citations: 225)

  7. Pattnaik, B., et al. (2017). Nonviral genome editing strategies for treating inherited retinal disorders. Investigative Ophthalmology & Visual Science. (Citations: 165)